Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin vs hydrochlorothiazide: effects on blood pressure and sympathetic nerve traffic in type 2 diabetes
2017-002175-25Phase 4Completed
- Sponsor
- Profil
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of empagliflozin in type 2 diabetes mellitus (T2DM) and hypertension (HTN) (2 arms), sponsored by Profil. Primary endpoint: Change in MSNA burst frequency. Started Jul 2017; status: completed.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on 2017-002175-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002175-25.